ChiCTR2000030028, 0 ChiCTR2000030028
anti-PD-1 antibody vs. standard of care
COVID 19 all comers
Chen, 2022
cilgavimab and tixagevimab (Evusheld) vs. control
COVID 19 all comers
ChiCTR2000030702, 0 ChiCTR2000030702
convalescent plasma treatment vs. control
COVID 19 all comers
ChiCTR2000030929, 0 ChiCTR2000030929
convalescent plasma treatment vs. placebo
COVID 19 all comers
NCT04323800, 0 NCT04323800
convalescent plasma treatment vs. standard of care
COVID 19 all comers
ChiCTR2000030039, 0 ChiCTR2000030039
convalescent plasma treatment vs. standard of care
COVID 19 all comers
LIFESAVER, 2021 NCT04374526
convalescent plasma treatment vs. standard of care
COVID 19 all comers
NCT04425837, 0 NCT04425837
convalescent plasma treatment vs. standard of care
COVID 19 all comers
TSUNAMI, 0 NCT04393727
convalescent plasma treatment vs. standard of care
COVID 19 all comers
ChiCTR2000030016, 0 ChiCTR2000030016
inactivated mycobacterium vaccine vs. standard of care
COVID 19 all comers
Cai -FAVIPIRAVIR, 2020 ChiCTR2000029600
interferon vs. interferon
COVID 19 all comers
Cai -FAVIPIRAVIR, 2020 ChiCTR2000029600
interferon vs. lopinavir/ritonavir
COVID 19 all comers
ChiCTR2000029989, 0 ChiCTR2000029989
interferon vs. placebo
COVID 19 all comers
NCT04331470, 0 NCT04331470
levamisole vs. lopinavir/ritonavir plus chloroquine
COVID 19 all comers
ACTIV-3 (BRII-196 and BRII-198), 2021 NCT04501978
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) vs. placebo
COVID 19 hospitalized
ACTIV-3/TICO LY-CoV555 , 2020 NCT04501978
bamlanivimab monotherapy vs. placebo
COVID 19 hospitalized
RECOVERY (REGN-COV2), 2021 NCT04381936
casirivimab/imdevimab (Ronapreve) vs. standard of care
COVID 19 hospitalized
ACTIV-3/TICO (tixa), 2022 NCT04501978
cilgavimab and tixagevimab (Evusheld) vs. placebo
COVID 19 hospitalized
Abolghasemi, 2020 IRCT20200325046860N1
convalescent plasma treatment vs. control
COVID 19 hospitalized
Salazar, 2020
convalescent plasma treatment vs. control
COVID 19 hospitalized
ESCAPE, 0 NCT04361253
convalescent plasma treatment vs. control
COVID 19 hospitalized
COVIPLASM (CORIMUNO-19 substudy), 0 NCT04345991
convalescent plasma treatment vs. control
COVID 19 hospitalized
C3PO, 0 NCT04355767
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
PassItOnII, 0 NCT04362176
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
CONTAIN COVID-19, 2021 NCT04364737
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
EPCOvid-1, 0 NCT04388410
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
CPC-SARS, 2021 NCT04405310
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
CAPRI, 0 NCT04421404
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
NCT04442191, 2021 NCT04442191
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
PROMETEO, 0 NCT04452812
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
Bennett-Guerrero, 2021 NCT04344535
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
LACCPT, 2021 PACTR202006760881890
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
CCAP-2, 2021 NCT04345289
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
Baldeon, 2022 SRCTN85216856
convalescent plasma treatment vs. placebo
COVID 19 hospitalized
ConCOVID (Gharbharan et al.), 2020 NCT04342182
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Dai W, 2020
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
ConPlas-19, 2020 NCT04345523
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
COP-COVID-19, 2021 NCT04358783
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
PC/COVID-19, 2021 NCT04366245
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04456413, 0 NCT04456413
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
CONCOR-KIDS, 0 NCT04377568
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04397757, 2021 NCT04397757
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
PLACO-COVID, 2021 NCT04428021
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
CONCOR-1, 2021 NCT04348656
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
SARS-CoV-2CP-HD-001, 0 2020-001632-10
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
DAWN-Plasma, 2021 NCT04429854
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
PLASCOSSA, 0 NCT04372979
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04385199, 2021 NCT04385199
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04391101, 0 NCT04391101
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04385186, 0 NCT04385186
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04395170, 0 NCT04395170
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
COPLA-II trial, 2020 NCT04425915
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04380935, 0 NCT04380935
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04403477 (two doses), 2021 NCT04403477
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
ASCOT, 2021 NCT04483960
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04374487 , 0 NCT04374487
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
RECOVERY (plasma), 2021 NCT04381936
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04649879, 0 NCT04649879
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
CONFIDENT, 2020 NCT04558476
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
PERUCONPLASMA, 2021 NCT04497324
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Salman, 2020 NCT04530370
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Kirenga, 2021 NCT04542941
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Co-CLARITY, 2021 NCT04567173
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
NCT04528368, 2021 NCT04528368
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Holm K, 2021 NCT04600440
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Bargay-Lleonart, 2022
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Menichetti, 2021 NCT04716556
convalescent plasma treatment vs. standard of care
COVID 19 hospitalized
Balcells, 2020 NCT04375098
Early convalescent plasma. vs. Deferred Convalescent plasma
COVID 19 hospitalized
Darazam, 2021 NCT04521400
high-dose IFN beta-1a vs. IFN beta-1a
COVID 19 hospitalized
SOLIDARITY (interferon), 2020 NCT04315948
IFN beta-1a vs. control
COVID 19 hospitalized
Esquivel-Moynelo, 2020 RPCEC00000307
IFN gamma vs. standard of care
COVID 19 hospitalized
Sakoulas, 2020 NCT04411667
immunoglobulin therapy vs. standard of care
COVID 19 hospitalized
Parikh, 2021 CTRI/2020/09/027903
immunoglobulin therapy vs. standard of care
COVID 19 hospitalized
Wang (early IFN), 2020
interferon vs. control
COVID 19 hospitalized
Wang, 2020
interferon vs. lopinavir/ritonavir
COVID 19 hospitalized
NCT04350671, 0
interferon vs. placebo
COVID 19 hospitalized
ITAC, 2022 NCT04546581
neutralizing antibody vs. placebo
COVID 19 hospitalized
Li, 2021 ChiCTR2000029638
recombinant super-compound interferon rSIFN-co vs. IFN alpha
COVID 19 hospitalized
Synairgen SG016, 2020 NCT04385095
SNG001 inhaled interferon beta vs. placebo
COVID 19 hospitalized
SPRINTER, 2022 NCT04732949
SNG001 inhaled interferon beta vs. placebo
COVID 19 hospitalized
ACTIV-3/ TICO (sotrovimab), 2021 NCT04501978
sotrovimab (Xevudy; VIR-7831) vs. placebo
COVID 19 hospitalized
phase 2, 0 NCT04787211
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) vs. placebo
COVID-19 mild to moderate
CORIMUNO-NIVO, 0 NCT04343144
anti-PD-1 antibody vs. standard of care
COVID-19 mild to moderate
CORIMMUNO-BEVA, 0 NCT04344782
bevacizumab vs. standard of care
COVID-19 mild to moderate
Suzuki, 2021
casirivimab/imdevimab (Ronapreve) vs. control
COVID-19 mild to moderate
Somersan-Karakaya (Cohort 1, Cohort 1A; Combined doses), 2021 NCT04426695
casirivimab/imdevimab (Ronapreve) vs. placebo
COVID-19 mild to moderate
Libster, 2020 NCT04479163
convalescent plasma treatment vs. placebo
COVID-19 mild to moderate
CORIPLASM, 0 NCT04345991
convalescent plasma treatment vs. standard of care
COVID-19 mild to moderate
PLACID, 2020 CTRI/2020/04/024775
convalescent plasma treatment vs. standard of care
COVID-19 mild to moderate
NCT04343768, 0 NCT04343768
interferon vs. interferon
COVID-19 mild to moderate
Hassaniazad, 2020 IRCT20200506047323N3
interferon vs. lopinavir/ritonavir plus interferon ß-1a
COVID-19 mild to moderate
COVID-Lambda, 0 NCT04331899
interferon vs. standard of care
COVID-19 mild to moderate
Fu, 2020 ChiCTR2000030262
interferon / TFF2 vs. standard of care
COVID-19 mild to moderate
Jagannathan, 2020 NCT04331899
peginterferon vs. placebo
COVID-19 mild to moderate
Pandit, 2021 CTRI/2020/06/026087
pegylated interferon-α2b vs. standard of care
COVID-19 mild to moderate
Shashi Bhushan, 2021 CTRI/2020/12/029855
pegylated interferon-α2b vs. standard of care
COVID-19 mild to moderate
Lattmann, 2021 CTRI/2020/10/028423
PNB001 vs. standard of care
COVID-19 mild to moderate
POLYCOR phase IIb (Gaborit), 2021 NCT04453384
XAV-19 vs. placebo
COVID-19 mild to moderate
ChiCTR2000029806 (camrelizumab), 0 ChiCTR2000029806
anti-PD-1 antibody vs. standard of care
COVID-19 severe or critically
COPERNICO, 0 NCT04335305
anti-PD-1 antibody vs. tocilizumab
COVID-19 severe or critically
NCT04317040, 0 NCT04317040
CD24Fc vs. placebo
COVID-19 severe or critically
Duan, 2020
convalescent plasma treatment vs. control
COVID-19 severe or critically
Sean, 2020
convalescent plasma treatment vs. control
COVID-19 severe or critically
Hegerova, 2020
convalescent plasma treatment vs. control
COVID-19 severe or critically
Joyner, 2020 NCT04338360
convalescent plasma treatment vs. convalescent plasma treatment
COVID-19 severe or critically
Gonzales, 2021 NCT04381858
convalescent plasma treatment vs. immunoglobulin therapy
COVID-19 severe or critically
ILBS-COVID-02 (Bajpai M), 2020 NCT04346446
convalescent plasma treatment vs. placebo
COVID-19 severe or critically
O’Donnell, 2021 NCT04359810
convalescent plasma treatment vs. placebo
COVID-19 severe or critically
NCT04400058, 0 NCT04400058
convalescent plasma treatment vs. placebo
COVID-19 severe or critically
PlasmAr, 2020 NCT04344535
convalescent plasma treatment vs. placebo
COVID-19 severe or critically
PLASM-AR, 0 NCT04383535
convalescent plasma treatment vs. placebo
COVID-19 severe or critically
ChiCTR2000030627, 0 ChiCTR2000030627
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
CP-COVID-19, 2021 NCT04332835
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Li, 2020 ChiCTR2000029757
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Rasheed, 2020
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
COV2-CP, 0 NCT04385043
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
CAPSID, 2021 NCT04433910
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
AlQahtani, 2020 NCT04356534
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
REMAP-CAP (plasma), 2021 NCT02735707
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
RECOVER, 2021 EudCT 2020-001632-10
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
PICP19 (Ray), 2020 CTRI/2020/05/025209
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Bihariesingh-Sanchit (SuriCovid), 2021 ISRCTN18304314
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Pouladzadeh, 2021 IRCT20200310046736N1
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Sekine (PLACOVID), 2021 NCT04547660
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Ray, 2022
convalescent plasma treatment vs. standard of care
COVID-19 severe or critically
Lopardo, 2021 NCT04494984
equine polyclonal antibodies INM005 vs. placebo
COVID-19 severe or critically
Kalil (ACTT-3), 2021 NCT04492475
IFN beta-1a vs. placebo
COVID-19 severe or critically
Davoudi-Monfared, 2020 IRCT20100228003449N2
IFN beta-1a vs. standard of care
COVID-19 severe or critically
Darazam (COVIFERON Interferon beta-1a), 2021 NCT04343768
IFN beta-1a vs. standard of care
COVID-19 severe or critically
Rahmani, 2020 IRCT20100228003449N2
IFN beta-1b vs. standard of care
COVID-19 severe or critically
Darazam (COVIFERON Interferon beta-1b), 2021 NCT04343768
IFN beta-1b vs. standard of care
COVID-19 severe or critically
Gharebaghi, 2020 IRCT20200501047259N1
immunoglobulin therapy vs. placebo
COVID-19 severe or critically
Tabarsi, 2020 IRCT20151227025726N2
immunoglobulin therapy vs. standard of care
COVID-19 severe or critically
Raman, 2021 CTRI/2020/06/026222
immunoglobulin therapy vs. standard of care
COVID-19 severe or critically